Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ananthakrishnan

Showing results (581-590 of 592) with videos related to

Pageof 60
Sort By:
Gastroenterology|March 15, 2024
Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel DiseaseMichelle Khrom, Millie Long, Shishir Dube, et al.
The American Journal of Gastroenterology|September 30, 2018
The Effect of Early-Life Environmental Exposures on Disease Phenotype and Clinical Course of Crohn's Disease in ChildrenLivia Lindoso, Kajari Mondal, Suresh Venkateswaran, et al.
BMJ Open Gastroenterology|March 31, 2025
Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and protocol for an open-label, multicentre, pragmatic, randomised controlled trialSiddharth Singh, Jasmine D Nguyen, David I Fudman, et al.
The Lancet. Gastroenterology & Hepatology|January 20, 2022
Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel DiseasesLucas Guillo, Maria Abreu, Remo Panaccione, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 21, 2022
IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL ConsensusBénédicte Caron, Maria T Abreu, Corey A Siegel, et al.
Nature|May 31, 2019
Multi-omics of the gut microbial ecosystem in inflammatory bowel diseasesJason Lloyd-Price, Cesar Arze, Ashwin N Ananthakrishnan, et al.
Nature Communications|September 14, 2016
Erratum: A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitisManuel A Rivas, Daniel Graham, Patrick Sulem, et al.
Gut|April 20, 2023
Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosisMarzieh Akhlaghpour, Talin Haritunians, Shyam K More, et al.
JAMA|February 27, 2019
Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel DiseaseGareth J Walker, James W Harrison, Graham A Heap, et al.
Nature Communications|August 10, 2016
A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitisManuel A Rivas, Daniel Graham, Patrick Sulem, et al.
Pageof 60

Showing results (581-590 of 592) with videos related to

Sort By:
Pageof 60
Gastroenterology|March 15, 2024
Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel DiseaseMichelle Khrom, Millie Long, Shishir Dube, et al.
The American Journal of Gastroenterology|September 30, 2018
The Effect of Early-Life Environmental Exposures on Disease Phenotype and Clinical Course of Crohn's Disease in ChildrenLivia Lindoso, Kajari Mondal, Suresh Venkateswaran, et al.
BMJ Open Gastroenterology|March 31, 2025
Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and protocol for an open-label, multicentre, pragmatic, randomised controlled trialSiddharth Singh, Jasmine D Nguyen, David I Fudman, et al.
The Lancet. Gastroenterology & Hepatology|January 20, 2022
Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel DiseasesLucas Guillo, Maria Abreu, Remo Panaccione, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 21, 2022
IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL ConsensusBénédicte Caron, Maria T Abreu, Corey A Siegel, et al.
Nature|May 31, 2019
Multi-omics of the gut microbial ecosystem in inflammatory bowel diseasesJason Lloyd-Price, Cesar Arze, Ashwin N Ananthakrishnan, et al.
Nature Communications|September 14, 2016
Erratum: A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitisManuel A Rivas, Daniel Graham, Patrick Sulem, et al.
Gut|April 20, 2023
Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosisMarzieh Akhlaghpour, Talin Haritunians, Shyam K More, et al.
JAMA|February 27, 2019
Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel DiseaseGareth J Walker, James W Harrison, Graham A Heap, et al.
Nature Communications|August 10, 2016
A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitisManuel A Rivas, Daniel Graham, Patrick Sulem, et al.
Pageof 60